Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users

American Journal of Gastroenterology

Volumn 103, Issue 5, 2008, Pages 1097-1103

  Coté, Gregory A ^a   Rice, John P ^a   Bulsiewicz, William ^a   Norvell, John P ^a   Christensen, Keri ^b   Bobb, Anne ^b   Postelnick, Michael ^b   Howden, Colin W ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; ESOMEPRAZOLE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; STEROID;

ADULT; AGED; CHI SQUARE TEST; COMPUTER; DRUG USE; FEMALE; GASTRODUODENAL ULCER; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL RECORD REVIEW; NORMAL HUMAN; OUTCOME ASSESSMENT; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH PROTECTION;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARDIOLOGY; CORONARY CARE UNITS; FEMALE; GASTROENTEROLOGY; HUMANS; INSERVICE TRAINING; INTERNSHIP AND RESIDENCY; MALE; MEDICAL ORDER ENTRY SYSTEMS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; MISOPROSTOL; OMEPRAZOLE; PATIENT DISCHARGE; PEPTIC ULCER HEMORRHAGE; PROTON PUMP INHIBITORS; RISK FACTORS; SOFTWARE; TELEMETRY;

EID: 43549119057     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01907.x     Document Type: Review

References (37)

1. van Leerdam ME, Vreeburg EM, Rauws EA, et al. Acute upper GI bleeding: Did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003 98 : 1494 9.
2. Lewis JD, Bilker WB, Brensinger C, et al. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: Relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol 2002 97 : 2540 9.
3. Lai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002 346 : 2033 8.
4. Lanas A, Perez-Aisa MA, Feu F, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005 100 : 1685 93.
5. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysis. BMJ 2000 321 : 1183 7.
6. McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med 2006 119 : 624 38.
7. Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med 2002 162 : 2197 202.
8. Laine L. Review article: Gastrointestinal bleeding with low-dose aspirin - what's the risk? Aliment Pharmacol Ther 2006 24 : 897 908.
9. Sorensen HT, Mellemkjaer L, Blot WJ, et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000 95 : 2218 24.
10. Shorr RI, Ray WA, Daugherty JR, et al. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993 153 : 1665 70.
11. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 1998 93 : 2037 46.
12. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995 123 : 241 9.
13. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999 340 : 1888 99.
14. Robinson MG, Griffin JW Jr., Bowers J, et al. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 1989 34 : 424 8.
15. Ehsanullah RS, Page MC, Tildesley G, et al. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controlled trial of ranitidine. BMJ 1988 297 : 1017 21.
16. Graham DY, Agrawal NM, Campbell DR, et al. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: Results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol versus lansoprazole. Arch Intern Med 2002 162 : 169 75.
17. Scheiman JM, Yeomans ND, Talley NJ, et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 2006 101 : 701 10.
18. Vonkeman HE, Fernandes RW, van de Laar MA. Under-utilization of gastroprotective drugs in patients with NSAID-related ulcers. Int J Clin Pharmacol Ther 2007 45 : 281 8.
19. Sturkenboom MC, Burke TA, Dieleman JP, et al. Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology (Oxford) 2003 42 (Suppl 3 III23 31.
20. Smalley W, Stein CM, Arbogast PG, et al. Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs. Arthritis Rheum 2002 46 : 2195 200.
21. Targownik LE, Al-Mamfud A. The prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular disease. Aliment Pharmacol Ther 2006 23 : 743 9.
22. Goldstein JL, Howard KB, Walton SM, et al. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications. Clin Gastroenterol Hepatol 2006 4 : 1337 45.
23. Whitley HP, Fermo JD, Chumney EC. 5-year evaluation of electronic medical record flag alerts for patients warranting secondary prevention of coronary heart disease. Pharmacotherapy 2006 26 : 682 8.
24. Smith DH, Perrin N, Feldstein A, et al. The impact of prescribing safety alerts for elderly persons in an electronic medical record: An interrupted time series evaluation. Arch Intern Med 2006 166 : 1098 104.
25. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005 352 : 969 77.
26. Eslami S, Abu-Hanna A, de Keizer NF. Evaluation of outpatient computerized physician medication order entry systems: A systematic review. J Am Med Inform Assoc 2007;14:400-6.
27. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987 40 : 373 83.
28. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: The Charlson comorbidity index. Methods Inf Med 1993 32 : 382 7.
29. Cote GA, Norvell JP, Rice JP, et al. Use of GI prophylaxis in patients discharged from hospital on ulcerogenic medicines [abstract]. Gastroenterology 2006 130 : A267 8.
30. Shuval K, Shachak A, Linn S, et al. The impact of an evidence-based medicine educational intervention on primary care physicians: A qualitative study. J Gen Intern Med 2007 22 : 327 31.
31. Mansouri M, Lockyer J. A meta-analysis of continuing medical education effectiveness. J Contin Educ Health Prof 2007 27 : 6 15.
32. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: A disease-specific self-management intervention. Arch Intern Med 2003 163 : 585 91.
33. Lacy CR, Suh DC, Barone JA, et al. Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting. Arch Intern Med 2002 162 : 468 73.
34. Anderson FA Jr., Wheeler HB, Goldberg RJ, et al. Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med 1994 154 : 669 77.
35. Cohn SL, Adekile A, Mahabir V. Improved use of thromboprophylaxis for deep vein thrombosis following an educational intervention. J Hosp Med 2006 1 : 331 8.
36. Balas EA, Weingarten S, Garb CT, et al. Improving preventive care by prompting physicians. Arch Intern Med 2000 160 : 301 8.
37. Gillespie R. Manufacturing knowledge: A history of the Hawthorne experiments. Cambridge : Cambridge University Press, 1991.